A Randomized Double-Blinded Phase II Study to Determine Treatment Protocol for Hemoglobin Optimization to Prevent Transfusion and Adverse Events in Perioperative Patients With Iron Restricted Anemia
Phase of Trial: Phase II
Latest Information Update: 20 Sep 2019
Price : $35 *
At a glance
- Drugs Epoetin alfa (Primary) ; Iron sucrose (Primary)
- Indications Iron deficiency anaemia
- Focus Adverse reactions; Therapeutic Use
- Acronyms HOPE-Hb
- 17 Sep 2019 Status changed from not yet recruiting to recruiting.
- 02 Apr 2019 Planned initiation date changed from 1 Oct 2018 to 1 May 2019.
- 04 Sep 2018 Planned initiation date changed from 21 May 2018 to 1 Oct 2018.